
Cardiology
Advanced CKD: Rivaroxaban Adds Bleeding, Not Benefit
TRACK found no cardiovascular benefit and more major bleeding when low-dose rivaroxaban was added in stage 4–5 CKD or dialysis-dependent kidney failure.
Rayan Salih · August 26, 2026 · 6 min
